| 1988 |
Eastell R, Heath H III, Kumar R, Riggs BL. Hormonal factors: PTH, vitamin D, and calcitonin. In: Riggs BL, Melton LJ III, eds. Osteoporosis: Etiology, Diagnosis, and Management. New York, NY: Raven Press; 1988:373-388. |
0 |
0 |
| 2020 |
Whyte MP, Zhang F, Wenkert D, Mumm S, Berndt TJ, Kumar R. Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia. Bone. May 2020;134:115300. |
1 |
0 |
| 2021 |
Kritmetapak K, Kumar R. Phosphate as a signaling molecule. Calcif Tiss Int. January 2021;108(1):16-31. |
0 |
0 |
| 2020 |
Kotwal A, Ferrer A, Kumar R, Singh RJ, Murthy V, Schultz‐Rogers L, Zimmermann M, Lanpher B, Zimmerman K, Stabach PR, Klee E, Braddock DT, Wermers RA. Clinical and biochemical phenotypes in a family with ENPP1 mutations. J Bone Miner Res. April 2020;35(4):662-670. |
6 |
0 |
| 2021 |
Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R, Rauch F, Luca D, Cimms T, Roberts MS, San Martin J, Carpenter TO. Burosumab for the treatment of tumor‐induced osteomalacia. J Bone Miner Res. April 2021;36(4):627-635. |
5 |
4 |